*This webinar has no external funding sources.
*This webinar is supported, in part, by independent medical education grant funding from Amgen, AstraZeneca Pharmaceuticals LP and Merck & Co., Inc.
Head and Neck Squamous Cell Carcinoma
Immune Checkpoint Inhibitor-related Adverse Events
Immune Effector Cell-related Adverse Events
Renal Cell Carcinoma
Non-Small Cell Lung Cancer (NSCLC)
Lung Cancer and Mesothelioma
Nonmelanoma Skin Cancer
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org